The Company is in search of an exceptional leader in blood cancer research to take on the inaugural Leukaemia Foundation Tony Fini Chair in Blood Cancer. This prestigious role is pivotal in shaping the future of blood cancer research and driving both national and global progress in the field. The successful candidate will be responsible for providing intellectual and strategic leadership to an ambitious research agenda that focuses on advancing the understanding, prevention, detection, diagnosis, and treatment of blood cancer and related disorders. The Chair will be expected to have a strong international research profile, a proven track record in securing competitive funding, and a commitment to high-quality research outputs. Collaboration across academia, clinical practice, government, industry, and philanthropy is essential, as is the ability to build and mentor high-performing research teams. Applicants for the Leukaemia Foundation Tony Fini Chair in Blood Cancer at the company should be exceptional academics with a recognized doctoral qualification and a distinguished record in blood cancer or related disorders research. The role requires a candidate with a vision for establishing a sustainable, internationally recognized research program and a commitment to the highest standards of research integrity and governance. The ideal candidate will have a collaborative approach, the ability to engage with diverse audiences, and a strong focus on translating research for the benefit of consumers and communities. This is a unique opportunity to make a lasting contribution to the field of blood cancer research and to create a legacy through world-class research, collaboration, and translation.